Life Science REIT plc (LON:LABS)
London flag London · Delayed Price · Currency is GBP · Price in GBX
44.80
+0.50 (1.13%)
Apr 24, 2025, 4:35 PM BST

Life Science REIT Income Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Rental Revenue
16.3615.4813.121.28
Other Revenue
3.954.462.58-
Total Revenue
20.3119.9415.711.28
Revenue Growth (YoY
1.84%26.97%1130.11%-
Property Expenses
5.886.124.77-
Selling, General & Administrative
4.845.245.612
Total Operating Expenses
10.7211.3510.382
Operating Income
9.598.595.33-0.72
Interest Expense
-10.39-9.6-3.78-
Interest & Investment Income
4.013.661.10.02
Other Non-Operating Income
0.20.152.16-
EBT Excluding Unusual Items
3.42.794.8-0.71
Gain (Loss) on Sale of Assets
--0.32--
Asset Writedown
-17.38-22.85-31.3119.29
Other Unusual Items
--1.48-0.96-
Pretax Income
-13.98-21.85-27.4718.58
Income Tax Expense
--0.150.15-
Net Income
-13.98-21.71-27.6118.58
Net Income to Common
-13.98-21.71-27.6118.58
Basic Shares Outstanding
350350350350
Diluted Shares Outstanding
350350350350
EPS (Basic)
-0.04-0.06-0.080.05
EPS (Diluted)
-0.04-0.06-0.080.05
Dividend Per Share
0.0100.0200.040-
Dividend Growth
-50.00%-50.00%--
Operating Margin
47.20%43.06%33.93%-56.77%
Profit Margin
-68.83%-108.85%-175.81%1455.08%
EBIT
9.598.595.33-0.72
EBIT Margin
47.20%43.06%33.93%-56.77%
Revenue as Reported
20.3119.9415.711.28
Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.